Jul08Wed
In 2005, the Irish Chamber had the pleasure of welcoming Dr. Robert C. Gallo, MD as a keynote speaker. Dr. Gallo is the eminent scientist who became world famous in 1984 when he co-discovered HIV as the cause of AIDS. Click HERE to view more photos from that event.
An Old Vaccine May Help Against Coronavirus
A tablet for polio boosts innate immunity, which fights other viruses.
By Robert C. Gallo, MD, and Daniel J. Arbess
June 30, 2020
The Global Virus Network is a collaboration among virology researchers and social scientists to improve pandemic preparedness and response. We know that life must go on while work on a Covid-19 vaccine continues. We believe that as people return to work, their risk of infection can be minimized by applying an old vaccine known to be a potent stimulus of the innate immune system.
Jul08Wed
Jul08Wed
We are thrilled to welcome Dr. Paul McCracken to our Board of Directors. Many thanks to Susan Ruane, who recently served on our board representing ICON Clinical Research.
Dr. Paul McCracken, is the Vice President, Global Head of ICON Medical Imaging, and North Wales Site Head at ICON Plc.. Paul has over 20 years’ experience in imaging and pharmaceuticals, with a strong track record of applying imaging and biomarkers to drug discovery and development across a range of therapeutic areas. He joined ICON in 2016 having previously he founded and led the Imaging Centre of Excellence at Eisai Co.. Prior to Eisai, Paul worked at Merck Research Laboratories, where he developed preclinical and translational imaging biomarkers and strategies to assess new molecular and biologic entities. Paul holds a Bachelor of Science in Physics from The College of New Jersey, a Master of Science in Physics/Medical Physics from Wright State University and received his Ph.D. in Biomedical Engineering – Imaging from the Mayo Clinic College of Medicine.
Jul08Wed
PNC taps insider for newly created chief corporate responsibility post
Philadelphia Business Journal
By Patty Tascarella Senior Reporter, Pittsburgh Business Times
PNC Financial Services Group Inc., one of the largest banks in the Philadelphia area, named two additions to its executive committee on Tuesday.
Carole Brown will be head of PNC’s Asset Management Group and Richard K. Bynum will serve in the newly created role of chief corporate responsibility officer. Both executives will report to Bill Demchak, chairman, president and CEO.
Brown, who joined PNC (NYSE: PNC) in 2019 as chief change and risk officer for AMG and Corporate & Institutional Banking, will be responsible for leading PNC’s wealth management and private banking services for high-net-worth and ultra-high-net worth individuals and families, as well as custom investment and advisory solutions for institutional clients. She succeeds Michael Lyons, who was instrumental in recruiting Brown to PNC. Lyons, also a member of PNC’s executive committee, will continue to lead PNC’s C&IB group.
